repaglinide has been researched along with Diabetes Mellitus in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bindu, B; Manikandan, A; Vijayalakshmi, S | 1 |
| Larijani, B; Mohammad Amoli, M; Nourbakhsh, M; Razzaghy-Azar, M; Talea, A | 1 |
| Maiti, S; Moorthy, NSHN; Patel, J | 1 |
| Kumar Dubey, S; Taliyan, R; Venkata Krishna, K; Wadhwa, G | 1 |
| Onady, GM; Stolfi, A | 2 |
| Assael, BM; Ballmann, M; Holl, RW; Honer, M; Hubert, D; Kronfeld, K | 1 |
| Blondel, E; Fonrose, X; Mallaret, MP; Roustit, M; Villier, C | 1 |
| Cesar, LA; Ferreira, BM; Hueb, W; Moffa, P; Ramires, JA; Uchida, A | 1 |
| Busse, R; Kreis, J | 1 |
| Birkeland, KI; Bleskestad, IH | 1 |
| Backman, JT; Kajosaari, LI; Neuvonen, M; Neuvonen, PJ; Niemi, M | 1 |
| Dolff, S; Heemann, U; Janssen, OE; Kribben, A; Mann, K; Philipp, T; Pietruck, F; Türk, T; Witzke, O | 1 |
| Mooradian, AD; Thurman, JE | 1 |
| Mozersky, RP | 1 |
| Landgraf, R | 1 |
| Carlton, FB | 1 |
| Milla, C; Moran, A; Phillips, J | 1 |
| Pospísilová, Y | 1 |
| Koivisto, V | 1 |
6 review(s) available for repaglinide and Diabetes Mellitus
| Article | Year |
|---|---|
Drug treatments for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Bias; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Fasting; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Piperidines; Randomized Controlled Trials as Topic | 2020 |
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Topics: Administration, Oral; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Piperidines; Randomized Controlled Trials as Topic | 2016 |
Drug therapy of postprandial hyperglycaemia.
Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol; Insulin; Insulin Lispro; Islet Amyloid Polypeptide; Piperidines; Postprandial Period; Trisaccharides | 1999 |
Recent advances in the pharmacologic management of diabetes mellitus.
Topics: Acarbose; Administration, Oral; Carbamates; Chromans; Diabetes Mellitus; Drug Overdose; Emergencies; Humans; Hypoglycemic Agents; Insulin; Insulin Lispro; Metformin; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
[News in oral antidiabetic therapy].
Topics: Administration, Oral; Carbamates; Diabetes Mellitus; Humans; Hypoglycemic Agents; Pioglitazone; Piperidines; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
[Insulin analogs and new oral antidiabetic drugs].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
3 trial(s) available for repaglinide and Diabetes Mellitus
| Article | Year |
|---|---|
Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Topics: Adolescent; Algorithms; Carbamates; Child; Cystic Fibrosis; Diabetes Mellitus; Early Diagnosis; Humans; Hypoglycemic Agents; Insulin; Piperidines; Prospective Studies | 2014 |
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carbamates; Cross-Over Studies; Cytochrome P-450 CYP2C8; Diabetes Mellitus; Double-Blind Method; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Piperidines; Trimethoprim | 2004 |
Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.
Topics: Carbamates; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Kidney Transplantation; Male; Middle Aged; Piperidines; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2006 |
11 other study(ies) available for repaglinide and Diabetes Mellitus
| Article | Year |
|---|---|
Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
Topics: Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hypoglycemic Agents; Insulin; Molecular Structure; Piperazines; Pyridazines; Structure-Activity Relationship; Triazoles | 2020 |
Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports.
Topics: Benzamides; Carbamates; Diabetes Mellitus; Humans; Hypoglycemic Agents; Iran; Mutation; Piperidines | 2021 |
Repaglinide-laden hydrogel particles of xanthan gum derivatives for the management of diabetes.
Topics: Blood Glucose; Carbamates; Diabetes Mellitus; Humans; Hydrogels; Piperidines; Polysaccharides, Bacterial | 2022 |
Design and biological evaluation of Repaglinide loaded polymeric nanocarriers for diabetes linked neurodegenerative disorder: QbD-driven optimization, in situ, in vitro and in vivo investigation.
Topics: Animals; Diabetes Mellitus; Drug Carriers; Humans; Mice; Nanoparticles; Neurodegenerative Diseases; Particle Size; Polymers; Tissue Distribution | 2023 |
Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
Topics: Aged; Anti-Infective Agents, Urinary; Blood Glucose; Carbamates; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Drug Interactions; Energy Intake; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Piperidines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2010 |
[Electrocardiographic score: application in exercise test for the assessment of ischemic preconditioning].
Topics: Carbamates; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Ergometry; Female; Humans; Hypoglycemic Agents; Ischemic Preconditioning; Male; Middle Aged; Myocardial Ischemia; Observer Variation; Piperidines; Predictive Value of Tests | 2010 |
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
Topics: Carbamates; Cost Control; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclohexanes; Diabetes Mellitus; Eligibility Determination; Evidence-Based Medicine; Germany; Health Care Reform; Health Policy; Humans; Hypoglycemic Agents; Insurance Coverage; Nateglinide; National Health Programs; Phenylalanine; Piperidines; Prescription Drugs; Reimbursement Mechanisms; Technology Assessment, Biomedical | 2012 |
[Differences between oral antidiabetics].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2003 |
Pharmacologic management of diabetes mellitus.
Topics: Carbamates; Chromans; Diabetes Mellitus; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
[Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients].
Topics: Blood Glucose; Carbamates; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypoglycemic Agents; Obesity; Piperidines | 2000 |
Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
Topics: Adult; Blood Glucose; Carbamates; Cystic Fibrosis; Diabetes Mellitus; Female; Food; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Lispro; Male; Piperidines | 2001 |